Revolut has received conditional approval from the US Office of the Comptroller of the Currency to establish a national bank in Stamford, Connecticut, with a planned launch in early 2027 and an initial capital injection of about $95 million. The bank still requires final approvals from the FDIC, Federal Reserve, and OCC before it can begin operations. Revolut aims to offer checking accounts, credit cards, installment loans, foreign exchange, and a stablecoin product under this charter, moving away from relying on partner banks for US customers. This marks a significant step for Revolut to expand its full banking services in the US market, complementing its recent banking licenses in Europe and Australia.
Hutchison China MediTech Limited (HCM) received a Buy rating upgrade from Daiwa with a new price target of $18.50 following a major licensing deal with GSK. The agreement grants GSK exclusive rights to commercialize HCM's experimental cancer therapy ...
Duluth Holdings reported a strong Q2 earnings per share (EPS) of $0.50, far exceeding the consensus estimate of -$0.01, largely due to $0.44 per share from tariff refunds. Revenue reached $121.39 million, beating estimates but declining from the prev...
Estée Lauder Companies recently appointed new brand leaders, signaling strategic shifts in its competitive beauty market. An insider executive sold 7,766 shares worth over $802,000, leaving no remaining holdings. The company shows a high P/E ratio of...
HUTCHMED's shares surged 17.77% after announcing a major licensing deal with GSK for its preclinical cancer drug HMPL-A830. GSK gets exclusive rights outside Greater China, paying $110 million upfront plus up to $1.295 billion in milestone payments. ...
Genesco reported second-quarter earnings that surpassed analyst expectations, with an EPS loss of $0.83 versus the estimated loss of $1.37 per share. Although revenue fell 3% year-over-year to $529.86 million, the company improved its adjusted gross ...
